Chlamydia Vaccine Shows Promise in Early Trial
FRIDAY, April 12, 2024 (HealthDay News) — A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI). There is currently no vaccine for chlamydia, which is the most common bacterial STI inContinue Reading